Atea Pharmaceuticals, Inc(NASDAQ:AVIR) 
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, a novel antiviral agent that is in Phase II clinical trial for th...
Website: http://www.ateapharma.com
CEO: Jean-Pierre Sommadossi
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.80
H 2.98
L 2.75
C 2.79
V 393,407
10EMA 2.79
20EMA 2.79
60EMA 2.79
120EMA 2.79
250EMA 2.79